ArticleDrugs & aging2020
Comparison of Healthcare Resource Utilization and Costs between Rivaroxaban and Warfarin for Nonvalvular Atrial Fibrillation in a Skilled Nursing Facility Setting.
Dheeraj Mahajan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it